Lineage Cell Therapeutics, Inc. (LCTX)

Lineage Cell Therapeutics Market Cap

Lineage Cell Therapeutics has a market cap or net worth of $192.60 million as of July 26, 2024. Its market cap has decreased by -18.56% in one year.

• Market Cap: 192.60M
• Enterprise Value: 152.23M
• 1-Year Change: -18.56%
• Ranking: #3675
• Category: Micro-Cap
• Stock Price: $1.02

Market Cap Chart

Since December 1, 1998, Lineage Cell Therapeutics's market cap has increased from $147.40M to $192.60M, an increase of 30.67%. That is a compound annual growth rate of 1.05%.

Market Cap History

Date	Market Cap	% Change
Jul 25, 2024	196.40M	2.99%
Dec 29, 2023	190.70M	-4.12%
Dec 30, 2022	198.90M	-51.84%
Dec 31, 2021	413.00M	56.44%
Dec 31, 2020	264.00M	98.05%
Dec 31, 2019	133.30M	15.01%
Dec 31, 2018	115.90M	-57.51%
Dec 29, 2017	272.80M	-26.90%
Dec 30, 2016	373.20M	-4.09%
Dec 31, 2015	389.10M	25.52%
Dec 31, 2014	310.00M	28.15%
Dec 31, 2013	241.90M	51.38%
Dec 31, 2012	159.80M	-45.26%
Dec 30, 2011	291.90M	-26.38%
Dec 31, 2010	396.50M	181.41%
Dec 31, 2009	140.90M	234.68%
Dec 31, 2008	42.10M	347.87%
Dec 31, 2007	9.40M	54.10%
Dec 29, 2006	6.10M	10.91%
Dec 30, 2005	5.50M	-79.55%
Dec 31, 2004	26.90M	43.09%
Dec 31, 2003	18.80M	-10.05%
Dec 31, 2002	20.90M	-60.79%
Dec 31, 2001	53.30M	-37.37%
Dec 29, 2000	85.10M	-11.72%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
CVRx, Inc.	205.81M
Acumen Pharmaceuticals	204.87M
Ventyx Biosciences	204.45M
The Joint	204.09M
Century Therapeutics	201.11M
Biomea Fusion	196.26M
Molecular Partners AG	195.78M
OptimizeRx	195.49M